Protocol for Production of a Genetic Cross of the Rodent Malaria Parasites
January 3rd, 2011
15K views
Genetic crosses of rodent malaria parasites are performed by feeding two genetically distinct parasites to mosquitoes. Recombinant progeny are cloned from mouse blood after allowing mosquitoes to bite infected mice. This video shows how to produce genetic crosses of Plasmodium yoelii and is applicable to other rodent malaria parasites.
Overview
This video demonstrates the procedure for producing genetic crosses of the rodent malaria parasite Plasmodium yoelii to generate recombinant progeny. The method involves feeding mosquitoes with infected mice to facilitate genetic recombination.
Key Study Components
Area of Science
- Malaria research
- Genetic recombination
- Parasitology
Background
- Rodent malaria parasites can be genetically crossed to study their genetics.
- Understanding genetic determinants is crucial for malaria research.
- Recombinant progeny can provide insights into drug resistance and transmissibility.
- This method can be applied to various rodent malaria species.
Purpose of Study
- To produce genetic crosses of Plasmodium yoelii.
- To generate recombinant progeny for further analysis.
- To investigate genetic factors influencing malaria characteristics.
Methods Used
- Injection of mice with a mixed inoculum of two parental clones.
- Feeding infected mice to mosquitoes to facilitate zygote formation.
- Harvesting sporozoites from mosquito salivary glands.
- Re-injecting sporozoites into naive mice to obtain blood stage parasites.
Main Results
- Successful generation of recombinant progeny from genetic crosses.
- Characterization of recombinant clones through genotyping.
- Identification of 5-10% of cloned lines as recombinants.
- Insights into genetic determinants of drug resistance and transmissibility.
Conclusions
- The method is effective for producing genetic crosses in malaria research.
- Recombinant progeny can help answer critical questions in the field.
- This approach can be adapted for other rodent malaria parasites.
Frequently Asked Questions
What is the significance of genetic crosses in malaria research?
Genetic crosses help identify genetic determinants of traits such as drug resistance and transmissibility.
How are recombinant progeny generated?
Recombinant progeny are generated by feeding mosquitoes with infected mice and harvesting sporozoites.
What percentage of cloned lines are typically recombinants?
Typically, 5-10% of cloned lines will be identified as recombinants.
Can this method be applied to other malaria species?
Yes, the method is applicable to various rodent malaria parasites.
What is the role of genotyping in this study?
Genotyping is used to characterize recombinant clones and identify genetic markers.
What are the main goals of this experimental procedure?
The main goals are to produce genetic crosses and generate recombinant progeny for research.
Executive Industry Relevance
Genetic crossing of rodent malaria parasites enables systematic interrogation of genotype-phenotype relationships in a tractable model system. This approach supports target validation by linking genetic loci to phenotypes such as drug resistance and transmissibility, providing mechanistic de-risking for downstream therapeutic hypotheses. The method generates recombinant progeny for high-resolution mapping, accelerating lead identification in antiparasitic discovery programs.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by associating genetic loci with phenotypic traits like drug resistance.
- Operational Value: Produces recombinant progeny that clarify biological mechanisms underlying parasite virulence and drug response.
- Scientific Value: Supports predictive confidence through linkage mapping of traits to specific genomic regions.
Screening & Assay Development
- Scientific Value: Generates genetically diverse parasite lines for phenotypic screening against compound libraries.
- Operational Value: Establishes standardized biological systems with quantifiable outputs for assay reproducibility.
- Scientific Value: Enables preparation of clonal parasite populations for reliable compound evaluation in blood-stage assays.
Translational & Preclinical Research
- Scientific Value: Facilitates disease-relevant system modeling by reproducing key biological characteristics of human malaria parasites.
- Operational Value: Provides continuity from discovery through preclinical validation using isogenic recombinant lines.
- Scientific Value: Supports risk-adjusted advancement decisions by identifying genetic determinants of transmissibility and drug susceptibility.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from early target validation through lead identification to preclinical evaluation by generating defined genetic diversity for phenotypic analysis.
- Discovery Biology: Supports hypothesis testing and pathway clarification by enabling genetic recombination between phenotypically distinct parental strains.
- Screening: Delivers assay-ready recombinant progeny with standardized genetic backgrounds for compound screening campaigns.
- Analytics: Enables quantitative dependent variable measurements through genotyping of recombinant clones using microsatellite and SNP markers.
- Translational Research: Connects to preclinical continuity by producing parasite lines that model human malaria parasite traits relevant to therapeutic intervention.
- Enterprise Reuse: Establishes a reusable platform for generating genetic diversity across multiple rodent malaria species and phenotypic traits.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation through reduction of mechanistic ambiguity in genotype-phenotype mapping.
- Operational Value: Standardization and scalability of recombinant parasite production for consistent screening inputs.
- Strategic Value: Improved go/no-go decisions via early de-risking of targets based on genetic evidence from controlled crosses.
- Portfolio Impact: Risk-adjusted prioritization of leads supported by genetic evidence of trait inheritance and penetrance.
Implementation Considerations
- Requires expertise in parasite culture, mosquito handling, and genetic genotyping techniques.
- Dependent on animal facilities for mouse and mosquito maintenance and controlled infection protocols.
- Necessitates standardization across teams for parasite cloning, genotyping, and phenotypic assessment.
- Adaptation considerations include species-specific differences in gametocyte development and mosquito compatibility.
- Practical limitations include dependency on successful mosquito feeding and oocyst development for recombinant yield.
Biopharma FAQs
Why does null hypothesis testing matter for target validation in genetic crosses?
Null hypothesis testing determines whether observed phenotypic differences in recombinant progeny are statistically linked to specific genetic loci rather than random variation, providing evidence for target validation in malaria research.
How does independent variable isolation fit the discovery pipeline in parasite genetics?
Isolating independent variables such as specific genetic loci through controlled crosses enables clear association with dependent phenotypes like drug resistance, supporting mechanistic de-risking in early discovery.
What quantitative dependent variable measurements enable genetic linkage mapping?
Quantitative measurements such as parasite growth rate, drug susceptibility, and transmissibility phenotypes, when correlated with genotyping data, enable identification of genetic loci underlying traits of interest.
Why do replication requirements matter for cross-functional collaboration in genetic cross studies?
Replication ensures consistent recombinant progeny generation and phenotypic assessment across laboratories, enabling reliable data sharing and collaborative validation of genetic targets.
What statistical analysis capabilities are required before implementing genetic cross workflows?
Capabilities for linkage analysis, QTL mapping, and association testing between genetic markers and phenotypic traits are required to interpret recombinant progeny data and validate targets.
Chapters in this video
0:05
Title
1:16
Introduction
1:37
Infection of Laboratory Mice with Blood-Stage Malaria Parasites
4:06
Mixed Clone Infection of Mice
5:14
Feeding Mosquitoes
6:45
Dissecting Mosquito Midget and Counting Oocysts
8:58
Collecting Sporozoites from Mosquitoes by Centrifugation
10:56
Cloning Progeny from a Genetic Cross Using Limiting Dilution
12:57
Production of Recombinant Malaria Parasites by Genetic Cross
13:11
Conclusion
